Pharmaceutical companies aim for new COVID drugs to bolster their depleted arsenal – The Boston Globe
“It’s like a jumbo jet crashing every day,” said Jean-Pierre Sommadossi, chief executive of Atea Pharmaceuticals, a Boston company developing antiviral pills for COVID. “We cannot remain complacent. We have to do something.” While the number of cases in Massachusetts remains low by historical standards, coronavirus levels in Boston-area wastewater have increased this month. And …